Loading...
XHKG0239
Market cap97mUSD
Dec 27, Last price  
2.42HKD
1D
-2.02%
1Q
-0.41%
Jan 2017
-32.21%
Name

Pak Fah Yeow International Ltd

Chart & Performance

D1W1MN
XHKG:0239 chart
P/E
7.18
P/S
2.91
EPS
0.34
Div Yield, %
6.32%
Shrs. gr., 5y
—
Rev. gr., 5y
12.85%
Revenues
259m
+76.16%
89,382,69396,208,000100,090,000101,456,000114,449,000107,959,000107,889,000115,931,000128,543,000162,016,000187,453,000182,570,000183,159,000179,981,000141,665,000147,761,000109,343,000139,823,000147,200,000259,312,000
Net income
105m
+250.66%
43,669,58333,635,00042,097,00036,006,000-18,189,00059,567,00055,013,00046,228,00064,344,00070,880,000146,465,00061,014,00061,199,000102,589,00037,280,00036,046,000-38,356,00038,186,00029,955,000105,039,000
CFO
148m
+270.49%
15,415,99524,516,00028,096,00023,410,00038,803,00033,479,00034,819,00023,304,00070,872,00055,703,00041,144,00072,351,00065,421,00098,816,00055,658,00048,748,0008,260,00070,358,00039,920,000147,899,000
Dividend
Sep 27, 20240.03 HKD/sh
Earnings
Mar 24, 2025

Profile

Pak Fah Yeow International Limited, together with its subsidiaries, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under, as well as Fúzai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. The company was founded in 1927 and is headquartered in Wan Chai, Hong Kong.
URL
https://www.pakfahyeow.com/
IPO date
Dec 18, 1991
Employees
99
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
259,312
76.16%
147,200
5.28%
139,823
27.88%
Cost of revenue
108,686
93,103
88,782
Unusual Expense (Income)
NOPBT
150,626
54,097
51,041
NOPBT Margin
58.09%
36.75%
36.50%
Operating Taxes
23,767
7,815
8,736
Tax Rate
15.78%
14.45%
17.12%
NOPAT
126,859
46,282
42,305
Net income
105,039
250.66%
29,955
-21.56%
38,186
-199.56%
Dividends
(47,629)
(24,585)
(20,547)
Dividend yield
8.63%
6.36%
4.17%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,737
5,496
16,212
Long-term debt
2,073
2,073
Deferred revenue
39,050
36,773
38,836
Other long-term liabilities
8,032
5,350
6,146
Net debt
(265,674)
(442,668)
(450,727)
Cash flow
Cash from operating activities
147,899
39,920
70,358
CAPEX
(3,061)
(156)
(820)
Cash from investing activities
16,652
(156)
(565)
Cash from financing activities
(48,963)
(33,906)
(22,406)
FCF
149,943
43,404
52,687
Balance
Cash
277,607
180,340
178,281
Long term investments
(7,196)
269,897
290,731
Excess cash
257,445
442,877
462,021
Stockholders' equity
743,186
685,228
685,725
Invested Capital
559,557
313,113
305,396
ROIC
29.07%
14.97%
13.59%
ROCE
17.35%
6.70%
6.24%
EV
Common stock shares outstanding
311,640
311,640
311,640
Price
1.77
42.74%
1.24
-21.52%
1.58
-14.59%
Market cap
551,603
42.74%
386,434
-21.52%
492,391
-14.59%
EV
285,929
(56,234)
41,664
EBITDA
158,014
61,581
58,221
EV/EBITDA
1.81
0.72
Interest
615
644
567
Interest/NOPBT
0.41%
1.19%
1.11%